ABT
Abbott Laboratories
NYSE: ABT · HEALTHCARE · MEDICAL DEVICES
$90.79
-0.59% today
Updated 2026-04-30
Market cap
$158.70B
P/E ratio
25.58
P/S ratio
3.52x
EPS (TTM)
$3.57
Dividend yield
2.60%
52W range
$90 – $136
Volume
11.9M
WallStSmart proprietary scores
56
out of 100
Grade: C+
Hold
Investment rating
4.0
Growth
C4.8
Quality
C6.5
Profitability
B5.3
Valuation
C+3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$118.64
+30.68%
12-Month target
$103.22
+13.69%
Intrinsic (DCF)
$87.68
Margin of safety
-3.55%
6 Strong Buy16 Buy7 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $2.63B — positive
Risks
- Piotroski 3/9 — weak financial health
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $43.65B | $40.11B | $41.95B | $44.33B | $45.13B | $48.8B |
| Net income | $6.93B | $5.72B | $13.40B | $6.52B | $1.08B | — |
| EPS | — | — | — | — | $3.57 | $5.74 |
| Free cash flow | $7.80B | $5.06B | $6.35B | $7.39B | $2.63B | — |
| Profit margin | 15.88% | 14.27% | 31.95% | 14.72% | 13.90% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-31 | STRATTON, JOHN G | Buy | 382 | $102.67 |
| 2026-03-31 | ROMAN, MICHAEL F | Buy | 367 | $102.67 |
| 2026-03-31 | GONZALEZ, PATRICIA PAOLA | Buy | 321 | $102.67 |
Peer comparison
Smart narrative
Abbott Laboratories trades at $90.79. representing a P/E of 25.58x trailing earnings. Our Smart Value Score of 56/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $45.13B. with profit margins at 13.90%. Our DCF model estimates intrinsic value at $87.68.
Frequently asked questions
What is Abbott Laboratories's stock price?
Abbott Laboratories (ABT) trades at $90.79.
Is Abbott Laboratories overvalued?
Smart Value Score 56/100 (Grade C+, Hold). DCF value $87.68.
What is the price target of Abbott Laboratories (ABT)?
The analyst target price is $118.64, representing +30.7% upside from the current price of $90.79.
What is the intrinsic value of Abbott Laboratories (ABT)?
Based on our DCF model, intrinsic value is $87.68, a -3.5% margin of safety versus $90.79.
What is the future stock price of ABT by 2030?
Our research-backed model estimates Abbott Laboratories could reach $462.92 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Abbott Laboratories's revenue?
TTM revenue is $45.13B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.52x
ROE13.00%
Beta0.78
50D MA$104.96
200D MA$120.97
Shares out1.74B
Float1.73B
Short ratio—
Avg volume11.9M
Performance
1 week+0.22%
1 month-10.79%
3 months-16.44%
YTD-27.11%
1 year—
3 years—
5 years—